SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001193125-19-208678
Filing Date
2019-07-31
Accepted
2019-07-31 16:08:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A: AMENDMENT NO. 1 d780311dsctoia.htm SC TO-I/A 22132
  Complete submission text file 0001193125-19-208678.txt   23714
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filed by) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-87623 | Film No.: 19988802
SIC: 2834 Pharmaceutical Preparations